News
Novo Nordisk, the maker of Ozempic and Wegovy, has also jumped into the legal fight —this time by intervening in the OFA’s lawsuit against the FDA. The company supports the agency’s move to restrict ...
Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...
The tortoise (Eli Lilly) has caught the hare (Novo Nordisk), according to a report from BMO Capital Markets, which cites the superior commercial and clinical portfolios of the Indianapolis company ...
Leveraging AI, researchers have identified a naturally occurring molecule that can suppress appetite and facilitate weight loss in mice and pigs.
Diabetics given the pill called orforglipron lost 16 pounds, or 7.9% of their body weight, over a 40-week period.
Dr. DiFrancesco ( is deeply enthusiastic about new developments in the treatment of addiction and has launched a new website ...
Employers face rising GLP-1 demand. Here are tips to manage costs while maintaining care access.
Pfizer announced on Monday that it’s halting the development of its weight loss pill Danuglipron after a trial patient suffered a liver injury. According to a press […] ...
Former Playboy star Kendra Wilkinson revealed that she started taking a weight-loss drug but threw the medication away after ...
It's little secret that America has a weight problem. For decades, Americans have embraced and abandoned countless ...
Eli Lilly stock soared Thursday after the pharmaceutical giant said its new weight-loss pill had cleared a late-stage ...
The former Playboy model, 39, started injecting the drug after being body-shamed by internet trolls earlier this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results